LA
FLACW

Linden Advisors’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Linden Advisors’s Portfolio FLACW Stock Details FLACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-64,960
Closed -$79K – 755
2021
Q2 		$79K Hold
64,960
– – ﹤0.01% 785
2021
Q1 		$60K Buy
+64,960
New +$110K ﹤0.01% 702

Other funds holding FLACW

MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
DCM
DG Capital Management New York $475M AUM 36.12% 1-Year Est. Return
EAM
Exos Asset Management New York $2.32M AUM 108.13% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return
GL
Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Linden Advisors's FLACW Position: Q3 2021 in Review

Linden Advisors sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q3 2021, closing a stake of 64,960 shares — an estimated $79K sold.

Linden Advisors first reported a position in FLACW in Q1 2021 and held it in 2 quarters. The position peaked at $79K in Q2 2021. 24 funds tracked by Wall St. Rank hold FLACW as of Q3 2021.

  • Linden Advisors reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q3 2021 after selling out during the quarter.
  • Linden Advisors sold 64,960 Frazier Lifesciences Acquisition Corporation Warrant shares in Q3 2021, an estimated $79K.
  • Linden Advisors first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q1 2021 and held it in 2 quarters.
  • Linden Advisors's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $79K in Q2 2021.
  • 24 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q3 2021.

Based on Linden Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.